Curegen Pharmaceuticals
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $8.9M
Investors
- 7
About Curegen Pharmaceuticals
Based in Taizhou, China and established in 2010, Curegen Pharmaceuticals,Inc. operates as a pharmaceutical company which focuses on developing new drugs used in surgery and cancer treatment. The company is mainly engaged in the research and development of new drugs, new drug delivery technologies and the improvement of generic drugs. The company's main drugs include general and anti-tumor APIs, sterile lyophilized preparations, solid preparations and small volume injections.
Who invested in Curegen Pharmaceuticals
7 investors across 3 rounds
See all investors in Curegen Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curegen Pharmaceuticals
Who invested in Curegen Pharmaceuticals?
Curegen Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curegen Pharmaceuticals raised?
Curegen Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Curegen Pharmaceuticals last raise money?
Curegen Pharmaceuticals's most recent round on record is a Series C, in Sep 2020.
What does Curegen Pharmaceuticals do?
Based in Taizhou, China and established in 2010, Curegen Pharmaceuticals,Inc.
Where is Curegen Pharmaceuticals headquartered?
Curegen Pharmaceuticals is headquartered in Taizhou, China.
Which VCs invest in companies like Curegen Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Curegen Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Curegen Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.